Effectiveness and cost-effectiveness of first BCG vaccination against tuberculosis in school-age children without previous tuberculin test (BCG-REVAC trial): a cluster-randomised trial.

Pereira, SM; Barreto, ML; Pilger, D; Cruz, AA; Sant'Anna, C; Hijjar, MA; Ichihara, MY; Santos, AC; Genser, B; Rodrigues, LC; (2012) Effectiveness and cost-effectiveness of first BCG vaccination against tuberculosis in school-age children without previous tuberculin test (BCG-REVAC trial): a cluster-randomised trial. The Lancet infectious diseases, 12 (4). pp. 300-6. ISSN 1473-3099 DOI: https://doi.org/10.1016/S1473-3099(11)70285-7

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/S1473-3099(11)70285-7

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar